Tower Research Capital »

Aspire Biopharma Holdings shares owned by Tower Research Capital

Quarter-by-quarter ownership of Aspire Biopharma Holdings shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Aspire Biopharma Holdings

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Holdings held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Holdings by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.2k 2.2k 1.03

More positions owned by Tower Research Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shares Etf Trust Daily Semiconduc (SOXL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Inc Cap Stk Cl A (GOOGL)
Ishares Tr Core Us Aggbd Et (AGG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vaneck Etf Trust Pharmaceutcl Etf (PPH)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)

View all positions for Tower Research Capital

Top funds holding Aspire Biopharma Holdings

UBS Group
Morgan Stanley
Geode Capital Management
Crewe Advisors
Vanguard Capital Management
Toronto-Dominion Bank
Vanguard Fiduciary Trust
Tower Research Capital
Citigroup
Efficient Wealth Management
Advisor Group Holdings
SBI Securities
Caitong International Asset Management

View all funds holding Aspire Biopharma Holdings